ArticleImmunologic research2026
Mortality in Behçet's Syndrome in a non-endemic population: a 25-year cohort study.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mortality in Behçet's syndrome (BS) has been consistently associated with neurological and vascular involvement in studies from endemic regions. However, data from non-endemic countries remain limited. This study aimed to evaluate long-term mortality and identify factors associated with mortality in a large Brazilian cohort of patients with BS. We conducted a retrospective cohort study including 303 adult patients diagnosed with BS and followed at a tertiary referral center in São Paulo, Brazil, between January 2000 and December 2024. Demographic, clinical, comorbidity, and treatment data were collected. Mortality rates were assessed, and factors associated with mortality were analyzed using unadjusted Cox proportional hazards models, with hazard ratios (HRs) and 95% confidence intervals (CIs). Among the 303 patients included, 61.6% were female, with a median follow-up of 117 months (IQR 55-184). A total of 162 patients (53.4%) were lost to follow-up. Eight deaths (2.6%) occurred during the study period. Given the limited number of events, only exploratory, unadjusted analyses were performed. Pulmonary artery aneurysm (HR 28.44, 95% CI 3.32-243.52; p = 0.002), central nervous system (CNS) parenchymal involvement (HR 6.81, 95% CI 1.65-28.06; p = 0.008), diabetes mellitus (HR 6.72, 95% CI 1.67-27.03; p = 0.007), and malignancy (HR 8.81, 95% CI 2.02-38.50; p = 0.004) were associated with increased mortality. Our exploratory analyses suggest that vascular and neurological involvement, particularly pulmonary artery aneurysm and CNS parenchymal disease, may be associated with increased mortality in our population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.